Earnings History Data for Eyegate Pharmaceuticals, Inc. (EYEG) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Eyegate Pharmaceuticals, Inc.

EyeGate Pharmaceuticals, Inc. is a pharmaceutical company which is engaged in developing and commercializing therapeutics and drug delivery systems for treating diseases of the eye. The company's technology consists of EyeGate(R) II Delivery System. Its product pipeline includes EGP-437 which is in different clinical stage. EyeGate Pharmaceuticals, Inc. is based in WALTHAM, MA.

Release Date	Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
12-05-2021	AH	EYEG	Eyegate Pharmaceuticals, Inc.	27.68	-0.37	-0.41	-0.43	Eyegate Pharmaceuticals reports Q1 results [5/12/2021 4:44 PM]	3.80	-0.23 (-5.71%)	3.90	-0.13 (-3.23%)	3.20 - 8.18	22,084	20,000	400
Eyegate Pharmaceuticals reports Q1 results [5/12/2021 4:44 PM] EyeGate Pharma Reports First Quarter 2021 Financial Results and Provides Business Update [May-12-21 04:15PM]
25-03-2021	AH	EYEG	Eyegate Pharmaceuticals, Inc.	39.58	-0.52	-0.40	-0.76	Eyegate Pharmaceuticals misses on revenue [3/25/2021 4:43 PM]	5.17	0.10 (1.97%)	5.05	-0.02 (-0.39%)	3.20 - 8.18	7,369	20,000	3,736
Eyegate Pharmaceuticals misses on revenue [3/25/2021 4:43 PM] EyeGate Pharma Reports Full Year 2020 Financial Results and Provides Business Update [Mar-25-21 04:15PM]